Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Pharmaceutical

Daiichi Sankyo

Ken Keller

Amy Todd Klug

Lerryn Trzcinski

Brian Hauser

James Felix

Rich Jones

Mila Tartakovsky

Fussy Tracy

Kevin R Forrest

Matt Siegel

Michael Grosso

Barry Fortner

Daniel Switzer

Dale E. Shuster

Stu Mackey

Scott Cleve

Michele Schmidt

Barbara Tantillo Rn Bsn

Raquel Coca Lopez

Simon King

Kara Reheis

Hayes Williams

Ken Takeshita

The Global Operations Team at Daiichi Sankyo orchestrates and optimizes international business activities across various departments, including medical capabilities, data management, clinical development, regulatory strategy, and digital transformation. The team ensures seamless coordination and strategic alignment throughout the company's subsidiaries and divisions, advancing the development and delivery of pharmaceutical products on a global scale.

Global Operations Team

Oncology Research and Development Team

Clinical Research and Development

Clinical Operations

Global Operations Team

About

Team members

Other teams at Daiichi Sankyo

Oncology Research and Development Team

Clinical Research and Development

Clinical Operations